Received FDA Investigational Device Exemption (IDE) approval to begin clinical evaluation of CartRevive in the U.S.
Company Description
Hy2Care is a medtech company focused on developing CartRevive, a proprietary hydrogel implant designed to repair damaged cartilage in a minimally invasive way, offering a potential alternative to more invasive surgical treatments.
Market
Cartilage repair
Location
Netherlands
Coinvestors
European Innovation Council Fund, Brightlands Venture Partners, LIOF